These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 197198)

  • 1. Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas.
    Gomard E; Duprez V; Reme T; Colombani MJ; Levy JP
    J Exp Med; 1977 Oct; 146(4):909-22. PubMed ID: 197198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes.
    Gomard E; Duprez V; Henin Y; Levy JP
    Nature; 1976 Apr; 260(5553):707-9. PubMed ID: 177884
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of the proline assay in the study of anti-MSV cell-mediated immune reactions.
    Henin Y; Gomard E; Gisselbrecht S; Levy JP
    Br J Cancer; 1979 Jan; 39(1):51-63. PubMed ID: 215185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between H-2 and viral antigens in murine oncornavirus-induced tumours.
    Gomard E; Duprez V; Henin Y; Levy JP
    J Immunogenet; 1977 Feb; 4(1):35-45. PubMed ID: 192802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products.
    Billings P; Burakoff S; Dorf ME; Benacerraf B
    J Exp Med; 1977 May; 145(5):1387-92. PubMed ID: 67179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor.
    Germain RN; Dorf ME; Benacerraf B
    J Exp Med; 1975 Oct; 142(4):1023-8. PubMed ID: 809532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity to murine sarcoma virus induced tumours. IV. Direct cellular cytolysis of 51Cr labelled target cells in vitro and analysis of blocking factors which modulate cytotoxicity.
    Gorczynski RM; Knight RA
    Br J Cancer; 1975 Apr; 31(4):387-404. PubMed ID: 50851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple H-2 linked immune response gene control of H-2 D-associated T-cell-mediated lympholysis to trinitrophenyl-modified autologous cells: Ir-like genes mapping to the left of I-A and within the I region.
    Schmitt-Verhulst AM; Shearer GM
    J Exp Med; 1976 Dec; 144(6):1701-6. PubMed ID: 1087329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic specificity of cell-mediated antitumor reaction in the MSV system.
    Leclerc JC; Gomard E; Levy JP; Senik A
    Bibl Haematol; 1975 Oct; (43):173-6. PubMed ID: 60997
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of H-2 region in cytolysis of viral induced lymphomas by T lymphocytes].
    Gomard E; Duprez V; Lévy JP
    Ann Immunol (Paris); 1977; 128(1-2):7-9. PubMed ID: 300611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T-cell response to Ectromelia virus-infected cells. Different H-2 requirements for triggering precursor T-cell induction or lysis by effector T cells defined by the BALB/c-H-2db mutation.
    Blanden RV; McKenzie IF; Kees U; Melvold RW; Kohn HI
    J Exp Med; 1977 Sep; 146(3):869-80. PubMed ID: 70498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity against Moloney sarcoma virus in H-2Db mutant bm14 mice. Unimpaired tumor immunity despite absence of a virus-specific cytotoxic T-cell response.
    Stukart MJ; Boes J; Melief CJ
    Int J Cancer; 1984 Feb; 33(2):265-9. PubMed ID: 6319305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated lympholysis of N-(3-nitro-4-hydroxy-5-iodophenylacetyl)-beta-anaylglycylglycyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the murine major histocompatibility complex.
    Rehn TG; Shearer GM; Koren HS; Inman JK
    J Exp Med; 1976 Jan; 143(1):127-42. PubMed ID: 53266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor.
    Armerding D; Sachs DH; Katz DH
    J Exp Med; 1974 Dec; 140(6):1717-22. PubMed ID: 4139236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary virus-induced lymphomas evade T cell immunity by failure to express viral antigens.
    Vasmel WL; Sijts EJ; Leupers CJ; Matthews EA; Melief CJ
    J Exp Med; 1989 Apr; 169(4):1233-54. PubMed ID: 2538550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex.
    Shearer GM; Rehn TG; Garbarino CA
    J Exp Med; 1975 Jun; 141(6):1348-64. PubMed ID: 47900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic specificities of the cell-mediated anti-tumor reactions in the MSV system studied by the secondary chromium release test.
    Senik A; Gisselbrecht S; Levy JP
    Int J Cancer; 1975 Dec; 16(6):960-70. PubMed ID: 53211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-2 antigen-specific cytotoxic T cells induced by concanavalin A: estimation of their relative frequency.
    Bevan MJ; Langman RE; Cohn M
    Eur J Immunol; 1976 Mar; 6(3):150-6. PubMed ID: 62665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.